Meningitis-retention syndrome
Neurological disorder characterized by urinary retention and meningitis
Meningitis-retention syndrome (MRS) is a rare neurological disorder characterized by the combination of aseptic meningitis and acute urinary retention. This syndrome is considered a type of neurogenic bladder dysfunction associated with inflammation of the central nervous system.
Clinical Presentation
Meningitis-retention syndrome typically presents with symptoms of meningitis, such as headache, fever, and neck stiffness, alongside urinary retention. Patients may also experience other neurological symptoms, including photophobia, nausea, and vomiting. The urinary retention is often acute and may require catheterization for management.
Pathophysiology
The exact pathophysiology of meningitis-retention syndrome is not fully understood. It is hypothesized that inflammation of the meninges leads to dysfunction of the autonomic nervous system, particularly affecting the sacral spinal cord segments responsible for bladder control. This results in a failure of the bladder to contract properly, leading to urinary retention.

Diagnosis
Diagnosis of meningitis-retention syndrome involves a combination of clinical evaluation and diagnostic testing. Lumbar puncture is performed to assess the cerebrospinal fluid (CSF) for signs of aseptic meningitis, such as elevated white blood cell count and protein levels, with normal glucose levels. Imaging studies, such as MRI of the brain and spine, may be conducted to rule out other causes of the symptoms.
Management
Management of meningitis-retention syndrome focuses on symptomatic relief and addressing the underlying inflammation. Treatment may include the use of corticosteroids to reduce inflammation and antiviral or antibiotic therapy if an infectious cause is suspected. Urinary retention is managed with catheterization until normal bladder function is restored.
Prognosis
The prognosis for patients with meningitis-retention syndrome is generally favorable, with most individuals experiencing complete recovery of bladder function and resolution of meningitis symptoms. However, the duration of symptoms can vary, and some patients may experience recurrent episodes.
Related Pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian